ChiCTR2100050589
Untitled Trial
Phase IV clinical study evaluating the safety and immunogenicity of the third dose of inactivated SARS CoV 2 vaccine (Vero cells) in a population that did not respond to the first two doses of inactivated vaccine
The Afiliated Hospital of Yunnan University·Phase 4·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- The Afiliated Hospital of Yunnan University
- Funder
- Special Project for Yunnan Social Development
- Location
- China
Timeline & enrollment
- Phase
- Phase 4
- Start date
- N/A
- End date
- Aug 02, 2023
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100050589
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100050589 through Pure Global AI's free database. This Phase 4 trial is sponsored by The Afiliated Hospital of Yunnan University and is currently Recruiting. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.